NHS to provide remdesivir to Covid patients after joint EU deal

EU commission secures enough doses for 500,000 patients in 36 countries including UK

Covid patients in the NHS will be able to get treatment in the coming months with remdesivir, one of the drugs given to Donald Trump, after the European commission negotiated for enough doses for 500,000 patients in 36 countries including the UK.

There is a global shortage of remdesivir because the US bought up all stocks from the US-based manufacturer Gilead from June to October. Demand for the drug is ramping up following Trump’s treatment for Covid.

Continue reading…